Skip to main content

Loteprednol News

FDA Approves Eysuvis (loteprednol etabonate) Ophthalmic Suspension for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

WATERTOWN, Mass.--(BUSINESS WIRE)--Oct. 27, 2020-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative...

FDA Approves Inveltys (loteprednol etabonate) for Post-Operative Inflammation and Pain Following Ocular Surgery

WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 23, 2018-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Keratoconjunctivitis Sicca, Allergies, Rosacea

Loteprednol patient information at Drugs.com